Current and historical daily PE Ratio for AlzeCure Pharma AB (
OSTO:ALZCUR
) from 2018 to Jun 25 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. AlzeCure Pharma AB stock (OSTO:ALZCUR) PE ratio as of Jun 25 2024 is 0.
More Details
AlzeCure Pharma AB (OSTO:ALZCUR) PE Ratio (TTM) Chart
AlzeCure Pharma AB (OSTO:ALZCUR) PE Ratio (TTM) Historical Data
View and export this data going back to 2018. Start your Free Trial
Total 1298
- 1
- 2
- 3
- 4
- 5
- 6
- 15
AlzeCure Pharma AB PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-25 | At Loss | 2024-04-16 | At Loss |
2024-06-20 | At Loss | 2024-04-15 | At Loss |
2024-06-19 | At Loss | 2024-04-12 | At Loss |
2024-06-18 | At Loss | 2024-04-11 | At Loss |
2024-06-17 | At Loss | 2024-04-10 | At Loss |
2024-06-14 | At Loss | 2024-04-09 | At Loss |
2024-06-13 | At Loss | 2024-04-08 | At Loss |
2024-06-12 | At Loss | 2024-04-05 | At Loss |
2024-06-11 | At Loss | 2024-04-04 | At Loss |
2024-06-10 | At Loss | 2024-04-03 | At Loss |
2024-06-07 | At Loss | 2024-04-02 | At Loss |
2024-06-05 | At Loss | 2024-04-01 | At Loss |
2024-06-04 | At Loss | 2024-03-29 | At Loss |
2024-06-03 | At Loss | 2024-03-28 | At Loss |
2024-05-31 | At Loss | 2024-03-27 | At Loss |
2024-05-30 | At Loss | 2024-03-26 | At Loss |
2024-05-29 | At Loss | 2024-03-25 | At Loss |
2024-05-28 | At Loss | 2024-03-22 | At Loss |
2024-05-27 | At Loss | 2024-03-21 | At Loss |
2024-05-24 | At Loss | 2024-03-20 | At Loss |
2024-05-23 | At Loss | 2024-03-19 | At Loss |
2024-05-22 | At Loss | 2024-03-18 | At Loss |
2024-05-21 | At Loss | 2024-03-15 | At Loss |
2024-05-20 | At Loss | 2024-03-14 | At Loss |
2024-05-17 | At Loss | 2024-03-13 | At Loss |
2024-05-16 | At Loss | 2024-03-12 | At Loss |
2024-05-15 | At Loss | 2024-03-11 | At Loss |
2024-05-14 | At Loss | 2024-03-08 | At Loss |
2024-05-13 | At Loss | 2024-03-07 | At Loss |
2024-05-10 | At Loss | 2024-03-06 | At Loss |
2024-05-08 | At Loss | 2024-03-05 | At Loss |
2024-05-07 | At Loss | 2024-03-04 | At Loss |
2024-05-06 | At Loss | 2024-03-01 | At Loss |
2024-05-03 | At Loss | 2024-02-29 | At Loss |
2024-05-02 | At Loss | 2024-02-28 | At Loss |
2024-04-30 | At Loss | 2024-02-27 | At Loss |
2024-04-29 | At Loss | 2024-02-26 | At Loss |
2024-04-26 | At Loss | 2024-02-23 | At Loss |
2024-04-25 | At Loss | 2024-02-22 | At Loss |
2024-04-24 | At Loss | 2024-02-21 | At Loss |
2024-04-23 | At Loss | 2024-02-20 | At Loss |
2024-04-22 | At Loss | 2024-02-19 | At Loss |
2024-04-19 | At Loss | 2024-02-16 | At Loss |
2024-04-18 | At Loss | 2024-02-15 | At Loss |
2024-04-17 | At Loss | 2024-02-14 | At Loss |
AlzeCure Pharma AB (OSTO:ALZCUR) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
AlzeCure Pharma AB
ISIN : SE0010133785
Compare
Compare
Traded in other countries / regions
ALZCUR.SwedenAC6.Germany IPO Date
2018-11-28Description
AlzeCure Pharma AB is a Swedish pharmaceutical company engaged in drug research with a primary focus on Alzheimer's disease. The company develops several drugs within its three research platforms NeuroRestore, Alzstatin, and Painless. The company's drug candidates include; ACD440, which is in the clinical development phase for the treatment of neuropathic pain, ACD856, ACD857, ACD679, and ACD680 for the treatment of Alzheimer's disease, and ACD137 for the treatment of severe pain in conditions such as osteoarthritis.